PTJ
HRTX icon

Paul Tudor Jones’s Heron Therapeutics HRTX Stock Holding History

Paul Tudor Jones’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-110,121
Closed -$465K – 2586
2022
Q3 		$465K Buy
110,121
+66,115
+150% +$259K 0.01% 1455
2022
Q2 		$123K Sell
44,006
-62,647
-59% -$252K ﹤0.01% 1902
2022
Q1 		$610K Sell
106,653
-88,221
-45% -$646K 0.01% 1157
2021
Q4 		$1.78M Buy
+194,874
New +$1.99M 0.03% 692
2021
Q2 		– Sell
-51,690
Closed -$838K – 1730
2021
Q1 		$838K Buy
+51,690
New +$921K 0.02% 921
2020
Q3 		– Sell
-84,039
Closed -$1.24M – 1405
2020
Q2 		$1.24M Buy
+84,039
New +$1.38M 0.06% 414
2018
Q1 		– Sell
-81,951
Closed -$1.48M – 1092
2017
Q4 		$1.48M Buy
81,951
+61,309
+297% +$1,000K 0.04% 244
2017
Q3 		$333K Buy
20,642
+2,024
+11% +$31.7K 0.01% 792
2017
Q2 		$258K Buy
18,618
+1,724
+10% +$25K 0.01% 803
2017
Q1 		$253K Buy
+16,894
New +$234K 0.01% 1102
2016
Q2 		– Sell
-19,943
Closed -$379K – 1755
2016
Q1 		$379K Buy
+19,943
New +$393K 0.01% 1140
2015
Q4 		– Sell
-26,533
Closed -$647K – 1731
2015
Q3 		$647K Buy
26,533
+7,561
+40% +$252K 0.02% 614
2015
Q2 		$591K Buy
+18,972
New +$357K 0.02% 673
2014
Q3 		– Sell
-40,800
Closed -$503K – 1409
2014
Q2 		$503K Buy
40,800
+15,801
+63% +$189K 0.02% 533
2014
Q1 		$348K Buy
+24,999
New +$334K 0.01% 723

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Paul Tudor Jones's HRTX Position: Q4 2022 in Review

Paul Tudor Jones sold out of Heron Therapeutics (HRTX) in Q4 2022, closing a stake of 110,121 shares — an estimated $465K sold.

Paul Tudor Jones first reported a position in HRTX in Q1 2014 and held it in 15 quarters. The position peaked at $1.78M in Q4 2021. 176 funds tracked by Wall St. Rank hold HRTX as of Q4 2022.

  • Paul Tudor Jones reported no remaining Heron Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Paul Tudor Jones sold 110,121 Heron Therapeutics shares in Q4 2022, an estimated $465K.
  • Paul Tudor Jones first reported a position in Heron Therapeutics in Q1 2014 and held it in 15 quarters.
  • Paul Tudor Jones's Heron Therapeutics position peaked at $1.78M in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.